1 |
Kim SJ, Bai GH, Hong YP. Drug resistance of Mycobacterium tuberculosis in Korea. Int J Tuberc Lung Dis 1997;1: 302-8
ScienceOn
|
2 |
World Health Organization. Guidelines for the programmatic management of drug-resistant tuberculosis. WHO/HTM/TB/ 2006.361. Geneva, Switzerland: WHO; 2006
|
3 |
Jang SH, Cha YH, Ahn YM, Kim SJ. Drug-resistant tuberculosis in children. J Korean Pediatr Soc 1997;40:818-24
|
4 |
Pablos-Mendez A, Raviglione MC, Laszlo A, Binkin N, Rieder HL, Bustreo F, et al. Global surveillance for antituberculosis-drug resistance, 1994-1997. N Engl J Med 1998;338: 1641-9
DOI
PUBMED
ScienceOn
|
5 |
Torun T, Gungor G, Ozmen I, Bolukbasi Y, Maden E, Bicakci B, et al. Side effects associated with the treatment of multidrug-resistant tuberculosis. Int J Tuberc Lung Dis 2005;9:1373-7
|
6 |
Raviglione MC, Smith IM. XDR tuberculosis implications for global public health. N Engl J Med 2007;356:656-9
DOI
ScienceOn
|
7 |
Wane LG. Simple pyrazinamidase and urease tests for routine identification of mycobacteria. Am Rev Respir Dis 1974; 109:147-51
|
8 |
Korean Academy of Tuberculosis and Respiratory Diseases. Guideline for the management of pulmonary tuberculosis. Seoul: Korean Academy of Tuberculosis and Respiratory Diseases; 2005
|
9 |
Starke J. Tuberculosis in children. Prim Care 1996;23:861-81
DOI
ScienceOn
|
10 |
Bai GH, Park YK, Choi YW, Bai JI, Kim HJ, Chang CL, et al. Trend of anti-tuberculosis drug resistance in Korea, 1994-2004. Int J Tuberc Lung Dis 2007;11:571-6
ScienceOn
|
11 |
World Health Organization. Global map and information on XDR-TB [internet]. Geneva, Switzerland: WHO; 2007 [cited 2007 Dec 31]. Available from: http://www.who.int/tb/challenges/xdr/xdrmap_oct07_en.pdf
|
12 |
American Thoracic Society/Center for Disease Control and Prevention. Diagnostic standards and classification of tuberculosis in adults and children. Am J Respir Crit Care Med 2000;161:1376-95
PUBMED
ScienceOn
|
13 |
Kwon KB, Park JY, Yoon BY, Kim MR, Lee HJ, Kim EJ, et al. The significance of bacteriologic examination in the childhood tuberculosis. J Korean Pediatr Soc 1994;37:221-9
|
14 |
Nelson LJ, Schneider E, Wells CD, Moore M. Epidemiology of childhood tuberculosis in the united states, 19932001: The need for continued vgilance. Pediatrics 2004;114:333-41
DOI
PUBMED
ScienceOn
|
15 |
Kim SJ, Hong YP, Han YC, Kim SJ. Drug resistance of Mycobacterium tuberculosis in Korea. Tuberculosis Respir Dis 1991:38;99-107
DOI
ScienceOn
|
16 |
Centers for Disease Control and Prevention (CDC). Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drug-worldwide, 2000-2004. MMWR Morb Mortal Wkly Rep 2006;55:301-5
ScienceOn
|
17 |
World Health Organization. Global tuberculosis control: suveillance, planning, financing. WHO/HTM/TB 2006. 362. Geneva, Switzerland: WHO; 2006
|
18 |
Nelson LJ, Wells CD. Global epidemiology of childhood tuberculosis. Int J Tuberc Lung Dis 2004;8:636-47
ScienceOn
|
19 |
Ena J, Valls V. Short-course therapy with rifampin plus isoniazid compared with standard therapy with isoniazid, for latent tuberculosis infection: a meta-analysis. Clin Infect Dis 2005;40:670-6
DOI
ScienceOn
|
20 |
Zignol M, Hosseini MS, Wright A, Weezenbeek CL, Nunn P, Watt CJ, et al. Global incidence of multidrug-resistant tuberculosis. J Infect Dis 2006;194:479-85
DOI
ScienceOn
|
21 |
Schaaf HS, Marias BJ, Hesseling AC, Gie RP, Beyers N, Donald PR. Childhood drug-resistant tuberculosis in the Western Cape Province of South Africa. Acta Paediatrica 2006;95:523-8
DOI
ScienceOn
|
22 |
Ormerod LP. Rifampicin and isoniazid prophylactic chemotherapy for tuberculosis. Arch Dis Child 1998;78:169-71
DOI
PUBMED
|
23 |
Park YK, Park YS, Bai JY, Kim HJ, Lew WJ, Chang CH, et al. Primary drug resistance rate of the private sector in 2003-2005. Tuberc Respir Dis 2008;64:87-94
DOI
ScienceOn
|
24 |
Mukherjee JS, Rich ML, Socci AR, Joseph JK, Viru FA, Shin SS, et al. Programmes and principles in treatment of multidrug-resistant tuberculosis. Lancet 2004;363:474-81
DOI
ScienceOn
|
25 |
Dye C, Espinal MA, Watt CJ, Mbiaga C, Williams BG. Worldwide incidence of multidrug-resistant tuberculosis. J Infect Dis 2002;185:1197-202
DOI
ScienceOn
|
26 |
Bai GH. Anti-tuberculosis drug resistance in Korea. CDMR 2005;16:101-7
|
27 |
de Pontual L, Balu L, Ovetchkine P, Maury-Tisseron B, Lachassinne E, Cruaud P, et al. Tuberculosis in adolescents: A French retrospective study of 52 cases. Pediatr Infect Dis J 2006;25:930-2
DOI
ScienceOn
|
28 |
Schaaf HS, Gie RP, Kennedy M, Beyers N, Hesseling PB, Donald PR. Evaluation of young children in contact with adult multidrug-resistant pulmonary tuberculosis: a 30- month follow-up. Pediatrics 2002;109:765-71
DOI
ScienceOn
|
29 |
British Thoracic Association. A controlled trial of six months chemotherapy in pulmonary tuberculosis: first report: results during chemotherapy. Br J Dis Chest 1981;75:141-53
DOI
ScienceOn
|
30 |
World Health Organization. Anti-tuberculosis drug resistance in the world: 3rd Report: the WHO/IUATLD global project on anti-tuberculosis drug resistance surveillance 1999-2002 Geneva, Switzerland: WHO; 2004
|
31 |
Corbett EL, Watt CJ, Walker N, Maher D, Williams BG, Raviglione MC, et al. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med 2003;163:1009-21
DOI
ScienceOn
|
32 |
Centers for Disease Control and Prevention. Revised definition of extensively drug-resistant tuberculosis. MMWR 2006;55:1176
|
33 |
Steiner M, Cosio A. Primary tuberculosis in children : I. Incidence of primary drug resistant disease in 332 children observed between the years 1961 and 1964 at the Kings Country Medical Center of Brooklyn. N Engl J Med 1966; 274:755-9
DOI
PUBMED
ScienceOn
|
34 |
Ganetti G, Fox W, Khmenko A, Mahler HT, Menon NK, Mitchison DA, Rist N, Smelev NA. Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes. Bull Wld Hlth Org 1969;41:21-43
PUBMED
ScienceOn
|
35 |
Aziz MA, Wright A, Laszlo A, De Muynck A, Portaels F, Van Deun A, et al. Epidemiology of anti-tuberculosis drug resistance (the global project on anti-tuberculosis drug resistance surveillance): an updated analysis. Lancet 2006;368: 2142-54
DOI
ScienceOn
|
36 |
Choi JC, Lim SY, Suh GY, Chung MP, Kim HJ, Kwon OJ, et al. Drug resistance rates of Mycobacterium tuberculosis at a private referral center in Korea. J Korean Med Sci 2007;22:677-81
DOI
ScienceOn
|
37 |
Hesseling A, Schaaf H, Gie R, Starke J, Beyers N. A critical review of diagnostic approaches used in the diagnosis of childhood tuberculosis. Int J Tuberc Lung Dis 2002;6:1038- 45
ScienceOn
|